Goodrx: TD Cowen Maintains Buy Rating, Lowers PT to $6.

Monday, Nov 10, 2025 12:31 pm ET1min read
GDRX--

Goodrx: TD Cowen Maintains Buy Rating, Lowers PT to $6.

Goodrx: TD Cowen Maintains Buy Rating, Lowers PT to $6.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet